Latest Intraperitoneal hyperthermic chemoperfusion Stories
A new study suggests that certain peritoneal mesothelioma patients who undergo heated intraperitoneal chemotherapy (HIPEC) after surgery may have better outcomes with a closed abdomen technique
New international studies are helping doctors perfect the procedure that has quickly become the standard of care for peritoneal mesothelioma. Raleigh, NC (PRWEB)
New research finds that hospitals make money when some mesothelioma patients have post-surgical complications.
Peritoneal mesothelioma patients who undergo surgery and heated chemotherapy more than once may safely improve their odds of survival. Raleigh, NC (PRWEB) August
First Ever CTCA® Forum to Feature Leading Oncologists from Across the Country in an Interactive Seminar SCHAUMBURG, Ill., June 30, 2014 /PRNewswire-USNewswire/ -- Cancer Treatment Centers
A new study suggests that platinum-based carboplatin reduces hospital stays and produces better outcomes for peritoneal mesothelioma patients than another popular drug. Raleigh,
SCHAUMBURG, Ill., June 10, 2014 /PRNewswire-USNewswire/ -- Extensive clinical experience suggests that hyperthermic intraperitoneal chemotherapy (HIPEC) may play an important role in the ongoing
SCHAUMBURG, Ill., Feb.
MRHFM encourages laparoscopic surgery for mesothelioma cancer treatment as a recent study suggests that fewer surgical complications are related to laparoscopic surgery for treating patients with
A small French study finds that certain patients with peritoneal cancers like mesothelioma may have better outcomes with laparoscopic surgery than with a traditional open approach.